Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 15, 2012 - Issue 5
395
Views
15
CrossRef citations to date
0
Altmetric
Original Research Reports

Sympathetic nervous activity, depressive symptoms, and metabolic syndrome in black Africans: The sympathetic activity and ambulatory blood pressure in Africans study

&
Pages 562-568 | Received 16 Aug 2011, Accepted 06 Dec 2011, Published online: 10 Jan 2012

References

  • Akbaraly TN, Kivimäki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE. 2009. Association between metabolic syndrome and depressive symptoms in middle-aged adults: Results from the Whitehall II study. Diabetes Care. 32:499–504.
  • Björntorp P. 2001. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev. 2:73–86.
  • Davis MC, Twamley EW, Hamilton NA, Swan PD. 1999. Body fat distribution and hemodynamic stress responses in premenopausal obese women: A preliminary study. Health Psychol. 18:625–633.
  • Flaa A, Sandvik L, Kjeldsen SE, Eide IK, Rostrup M. Does sympathoadrenal activity predict changes in body fat? An 18-y follow-up study. Am J Clin Nutr. 2008a; 87:1596–1601.
  • Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: An 18-year follow-up study. Metabolism. 2008b; 57:1422–1427.
  • Flaa A, Eide IK, Kjeldsen SE, Rostrup M. Sympathoadrenal stress reactivity is a predictor of future blood pressure: An 18-year follow-up study. Hypertension. 2008c; 52:336–341.
  • Folkow B. 2000. Perspectives on the integrative functions of the ‘sympatho-adreno-medullary system’. Auton Neurosci. 83:101–115.
  • Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A. 2007. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol. 74:20–25.
  • Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M. 2010. Long-term stability of cardiovascular and catecholamine responses to stress tests: An 18-year follow-up study. Hypertension. 55:131–136.
  • Hellhammer DH, Wüst S, Kudielka BM. 2009. Salivary cortisol as biomarker in stress research. Psychoneuroendocrinology. 34:163–171.
  • Heppner P, Heppner MJ, Wang Y, Wang L. 2006. Development and validation of a collectivist coping styles inventory. J Couns Psychol. 53:107–125.
  • Jern S, Bergbrant A, Bjorntorp P, Hansson L. 1992. Relation of central hemodynamics to obesity and body fat distribution. Hypertension. 19:520–527.
  • Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. 2004. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res. 38:503–511.
  • Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M. 2008. Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study. J Clin Psychiatry. 69:178–182.
  • Kroenke K, Spitzer RL, Williams JB. 2001. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 16:606–613.
  • Kuniyoshi FH, Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Gowdak MM. 2003. Abnormal neurovascular control during sympathoexcitation in obesity. Obes Res. 11:1411–1419.
  • Licht CM, Vreeburg SA, van Reedt Dortland AK. 2010. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 95:2458–2466.
  • Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG. 2010. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 67:220–229.
  • Malan L, Malan NT, Wissing MP, Seedat YK. 2008. Coping with urbanization: A cardiometabolic risk? The THUSA study. Biol Psychol. 79:323–328.
  • Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S. 2007. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 25:909–920.
  • Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, Yebei VN, Ojwang C. 2009. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J Gen Intern Med. 24:189–197.
  • Muhtz C, Zyriax BC, Klähn T, Windler E, Otte C. 2009. Depressive symptoms and metabolic risk: Effects of cortisol and gender. Psychoneuroendocrinology. 34:1004–1011.
  • Räikkönen K, Matthews KA, Kuller LH. 2007. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care. 30:872–877.
  • Reaven GM, Lithell H, Landsberg L. 1996. Hypertension and associated metabolic abnormalities—The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:374–381.
  • Ryff CD, Singer B. 2002. From social structure to biology. In: Snyder CR, Lopez SJ. editors. Handbook of positive psychology. New York: Oxford University Press541–555.
  • Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. 2008. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study. Lancet. 371:915–922.
  • Slopen N, Lewis TT, Gruenewald TL. 2010. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 72:694–701.
  • Tomlinson M, Grimsrud AT, Stein DJ, Williams DR, Myer L. 2009. The epidemiology of major depression in South Africa: Results from the South African stress and health study. S Afr Med J. 99:367–373.
  • Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW. 2007. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 32:151–159.
  • Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM, Yaffe K, Harris TB, Penninx BW. 2008. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 65:1386–1393.
  • Yang RK, Yehuda R, Holland DD, Knott PJ. 1997. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Biol Psychiatry. 42:821–826.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.